TAFOLECIMAB

UNII: KV2ZKH0NIM
Preferred Substance Name: TAFOLECIMAB

2225109-03-3
IBI306
IBI-306
IMMUNOGLOBULIN IGG2, ANTI-(HUMAN PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9) (HUMAN MONOCLONAL IBI306 .GAMMA.2-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL IBI306 .KAPPA.-CHAIN, DIMER
TAFOLECIMAB [INN]
TAFOLECIMAB [WHO-DD]

Common Chemistry
i
Inxight Drugs
i
NCATS GSRS Full Record
i
NCI Thesaurus
i

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

About, Contact Us, Copyright, Privacy, Accessibility

U.S. Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993-0002

U.S. Food and Drug Administration, Health & Human Services

Freedom of Information Act

TAFOLECIMAB

Synonyms and Mappings

Resources

Note